Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Marex Group Limited Ordinary Shares (MRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Marex Group Limited Ordinary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.3 (market cap $12.58B), while Marex Group Limited Ordinary Shares trades at $70.61 (market cap $5.12B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 2.5× Marex Group Limited Ordinary Shares's market cap, and Marex Group Limited Ordinary Shares pays a 0.9% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Marex Group Limited Ordinary Shares for 0 Days on average.
| HALO | MRX | |
|---|---|---|
Market Cap | $12.58B | $5.12B |
Volume | 2,179,278 | 647,370 |
Sector | Health | Financials |
52-Week High | $115.22 | $78.27 |
52-Week Low | $61.63 | $29.92 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.49B | $8.20B |
Dividend Yield | — | 0.9% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Marex Group Limited Ordinary Shares
Marex Group provides financial services across commodities, financial markets, and corporate clients. Its services include clearing, agency and execution, market making, hedging, and securities services.
Read more on MRX →
